| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fb38ebd40c70e97cc5f1519c6699162 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1272 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-26 |
| filingDate |
2020-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da27673ba75a3e617f6013598c1778d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82e5742dd697bae0eb0eac8f605cfb2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0076aaffbbd2f0c58657694365904e6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a87f89c8b6441fef244acbeac4d908d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_898c6b426a218ffefb03a9db5f4e7683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b8925a5a5969e880e92c7505ed88fa0 |
| publicationDate |
2020-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111759834-A |
| titleOfInvention |
Application of sulforaphane or its nanoparticles in the preparation of medicines for improving embryonic nervous system dysplasia caused by intake of heterocyclic amines in pregnant women |
| abstract |
The invention discloses the application of sulforaphane or its nano-particles in preparing medicines for improving the dysplasia of embryonic nervous system caused by the intake of heterocyclic amines in pregnant women. The present invention provides a new application of sulforaphane-embryo development protection application, which not only expands the application scope of sulforaphane, improves its application value, but also helps to further develop new methods for improving the induction of pregnant women's heterocyclic amine intake. The nanomedicine of embryonic nervous system dysplasia has good application prospects. |
| priorityDate |
2020-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |